Artykuły udostępnione publicznie: - Filipe Brogueira RodriguesWięcej informacji
Dostępne w jakimś miejscu: 49
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
LM Byrne, FB Rodrigues, K Blennow, A Durr, BR Leavitt, RAC Roos, ...
The Lancet Neurology 16 (8), 601-609, 2017
Upoważnienia: Knut and Alice Wallenberg Foundation, Swedish Research Council, UK Medical …
Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis
RI Scahill, P Zeun, K Osborne-Crowley, EB Johnson, S Gregory, C Parker, ...
The Lancet Neurology 19 (6), 502-512, 2020
Upoważnienia: Alzheimers's UK, UK Medical Research Council, National Institute for Health …
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington’s disease
LM Byrne, FB Rodrigues, EB Johnson, PA Wijeratne, E De Vita, ...
Science translational medicine 10 (458), eaat7108, 2018
Upoważnienia: UK Engineering and Physical Sciences Research Council, UK Medical Research …
Deep brain stimulation for dystonia
FB Rodrigues, GS Duarte, D Prescott, J Ferreira, J Costa
The Cochrane database of systematic reviews 2019 (1), CD012405, 2019
Upoważnienia: National Institute for Health Research, UK
Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s disease
FB Rodrigues, LM Byrne, R Tortelli, EB Johnson, PA Wijeratne, M Arridge, ...
Science translational medicine 12 (574), eabc2888, 2020
Upoważnienia: Swedish Research Council for Environment, Agricultural Sciences and Spatial …
Neurofilament light protein in blood predicts regional atrophy in Huntington disease
EB Johnson, LM Byrne, S Gregory, FB Rodrigues, K Blennow, A Durr, ...
Neurology 90 (8), e717-e723, 2018
Upoważnienia: Knut and Alice Wallenberg Foundation, Swedish Research Council, UK Medical …
Cerebrospinal fluid inflammatory biomarkers reflect clinical severity in Huntington’s disease
FB Rodrigues, LM Byrne, P McColgan, N Robertson, SJ Tabrizi, ...
PloS one 11 (9), e0163479, 2016
Upoważnienia: Swedish Research Council, UK Biotechnology and Biological Sciences Research …
Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease
FB Rodrigues, L Byrne, P McColgan, N Robertson, SJ Tabrizi, BR Leavitt, ...
Journal of neurochemistry 139 (1), 22-25, 2016
Upoważnienia: Swedish Research Council, UK Biotechnology and Biological Sciences Research …
Fifteen years of clinical trials in Huntington’s disease: A very low clinical drug development success rate
AM Travessa, FB Rodrigues, TA Mestre, JJ Ferreira
Journal of Huntington's disease 6 (2), 157-163, 2017
Upoważnienia: US National Institutes of Health
Huntington’s Disease Clinical Trials Corner: February 2018
FB Rodrigues, EJ Wild
Journal of Huntington's Disease 7 (1), 89, 2018
Upoważnienia: UK Medical Research Council
Tetrabenazine versus deutetrabenazine for Huntington's disease: twins or distant cousins?
FB Rodrigues, GS Duarte, J Costa, JJ Ferreira, EJ Wild
Movement disorders clinical practice 4 (4), 582-585, 2017
Upoważnienia: UK Medical Research Council
Botulinum toxin type A versus anticholinergics for cervical dystonia
M Castelão, RE Marques, J Ferreira, C Sampaio, AP Moore, J Costa
Cochrane Database of Systematic Reviews, 2021
Upoważnienia: National Institute for Health Research, UK
Botulinum toxin type A therapy for cervical dystonia
RE Marques, M Castelão, J Ferreira, C Sampaio, AP Moore, J Costa
Cochrane Database of Systematic Reviews, 2020
Upoważnienia: National Institute for Health Research, UK
The use of wearable/portable digital sensors in Huntington's disease: a systematic review
R Tortelli, FB Rodrigues, EJ Wild
Parkinsonism & Related Disorders 83, 93-104, 2021
Upoważnienia: UK Medical Research Council
Morphine in acute coronary syndrome: systematic review and meta-analysis
G Duarte, A Nunes-Ferreira, FB Rodrigues, F Pinto, J Ferreira, J Costa, ...
BMJ Open, 2019
Upoważnienia: Fundação para a Ciência e a Tecnologia, Portugal
The adenosinergic system: a non-dopaminergic target in Parkinson’s disease
M Morelli, N Simola, J Wardas
Springer, 2015
Upoważnienia: US National Institutes of Health, German Research Foundation, Fundação para …
Clinical trials corner: September 2017
FB Rodrigues, EJ Wild
Journal of Huntington's disease 6 (3), 255-263, 2017
Upoważnienia: UK Medical Research Council
An MDS evidence‐based review on treatments for Huntington's disease
JJ Ferreira, FB Rodrigues, GS Duarte, TA Mestre, AC Bachoud‐Levi, ...
Movement Disorders 37 (1), 25-35, 2022
Upoważnienia: US National Institutes of Health, Austrian Science Fund, Canadian Institutes …
Botulinum toxin type A therapy for blepharospasm
RE Marques, M Castelão, J Ferreira, C Sampaio, AP Moore, J Costa
Cochrane Database of Systematic Reviews, 2020
Upoważnienia: National Institute for Health Research, UK
Huntington’s disease clinical trials corner: January 2019
FB Rodrigues, L Quinn, EJ Wild
Journal of Huntington's disease 8 (1), 115-125, 2019
Upoważnienia: UK Medical Research Council
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy